NuVasive Inc. (NASDAQ:NUVA) went up by 3.17% from its latest closing price compared to the recent 1-year high of $72.61. The company’s stock price has collected 3.03% of gains in the last five trading sessions. Press Release reported on 01/07/22 that Sorrento Therapeutics Announces the Unexpected Death of its Chief Financial Officer
Is It Worth Investing in NuVasive Inc. (NASDAQ :NUVA) Right Now?
Plus, the 36-month beta value for NUVA is at 1.19. Opinions of the stock are interesting as 8 analysts out of 17 who provided ratings for NuVasive Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 7 rated it as “hold,” and 1 as “sell.”
The average price from analysts is $64.73, which is $8.35 above the current price. NUVA currently public float of 51.42M and currently shorts hold a 7.06% ratio of that float. Today, the average trading volume of NUVA was 794.41K shares.
NUVA’s Market Performance
NUVA stocks went up by 3.03% for the week, with a monthly jump of 11.56% and a quarterly performance of -2.64%, while its annual performance rate touched -4.12%. The volatility ratio for the week stands at 4.67% while the volatility levels for the past 30 days are set at 4.19% for NuVasive Inc.. The simple moving average for the period of the last 20 days is 7.78% for NUVA stocks with a simple moving average of -8.29% for the last 200 days.
Analysts’ Opinion of NUVA
Many brokerage firms have already submitted their reports for NUVA stocks, with RBC Capital Mkts repeating the rating for NUVA by listing it as a “Outperform.” The predicted price for NUVA in the upcoming period, according to RBC Capital Mkts is $60 based on the research report published on December 10th of the previous year 2021.
UBS, on the other hand, stated in their research note that they expect to see NUVA reach a price target of $54, previously predicting the price at $59. The rating they have provided for NUVA stocks is “Sell” according to the report published on November 10th, 2021.
Truist gave a rating of “Buy” to NUVA, setting the target price at $75 in the report published on November 10th of the previous year.
NUVA Trading at 5.76% from the 50-Day Moving Average
After a stumble in the market that brought NUVA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -22.81% of loss for the given period.
Volatility was left at 4.19%, however, over the last 30 days, the volatility rate increased by 4.67%, as shares surge +15.05% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -0.94% lower at present.
During the last 5 trading sessions, NUVA rose by +3.03%, which changed the moving average for the period of 200-days by -14.51% in comparison to the 20-day moving average, which settled at $52.37. In addition, NuVasive Inc. saw 6.80% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at NUVA starting from Barry James Christopher, who sale 5,000 shares at the price of $70.00 back on Jun 25. After this action, Barry James Christopher now owns 9,926 shares of NuVasive Inc., valued at $350,000 using the latest closing price.
Barry James Christopher, the Chief Executive Officer of NuVasive Inc., sale 5,000 shares at $68.00 during a trade that took place back on Jun 21, which means that Barry James Christopher is holding 14,926 shares at $340,000 based on the most recent closing price.
Stock Fundamentals for NUVA
Current profitability levels for the company are sitting at:
- +4.78 for the present operating margin
- +56.28 for the gross margin
The net margin for NuVasive Inc. stands at -3.54. The total capital return value is set at 2.46, while invested capital returns managed to touch -2.18. Equity return is now at value -3.00, with -1.10 for asset returns.
Based on NuVasive Inc. (NUVA), the company’s capital structure generated 165.77 points at debt to equity in total, while total debt to capital is 62.37. Total debt to assets is 56.85, with long-term debt to equity ratio resting at 95.53. Finally, the long-term debt to capital ratio is 35.76.
When we switch over and look at the enterprise to sales, we see a ratio of 2.93, with the company’s debt to enterprise value settled at 0.45. The receivables turnover for the company is 5.02 and the total asset turnover is 0.46. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.87.